Epistemic fault lines in biomedical and social approaches to HIV prevention by Adam, Barry D
Traditional knowledge handed down from 
generation to generation helped to save ancient 
tribes on India’s Andaman and Nicobar Islands 
from the worst of the tsunami, anthropologists say.
BBC News, 20 January 2005 [1]
Th   e Bush Administration today announced a plan 
to expand U.S. tsunami detection and warning 
capabilities as part of the Global Earth 
Observation System of Systems (GEOSS), the 
international eﬀ  ort to develop a comprehensive, 
sustained and integrated Earth observation 
system. Th   e plan commits a total of 
$37.5 million over the next two years.
Oﬃ   ce of Science and Technology Policy, 
Executive Oﬃ   ce of the President, 
Washington, D.C., 
14 January 2005 
(http://dssresources.com/news/531.php)
Natural cataclysms like tsunamis and epidemics raise 
criti  cal questions concerning how best to allocate resources 
to research and action in order to avoid foreseeable 
recurrences. Th  is pair of news items, following the 26 
December 2004 tsunami oﬀ   the coast of Sumatra that 
killed 230,000 people in 14 countries, shows contrasting 
knowledge systems brought to bear in comprehending 
and constructing the nature of a problem and its 
response. On one side are decidedly low-tech indigenous 
knowledge and anthropological research; on the other is 
capital-intensive, high-tech seismic detection. Perhaps 
most notable is the almost reﬂ   ex endorsement of the 
latter knowledge system by the most powerful govern-
ment on the planet, and the complex, expensive, global 
infrastructure put in place to sustain that system.
Th   is small example in the sociology of science can be 
an occasion for reﬂ  ecting on the construction and in  sti-
tutionalization of knowledge in the HIV epidemic, in par-
ti  cular the overwhelming belief in, and institutionalization 
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zation – even at times, erasure – of indigenous know-
ledges of aﬀ   ected communities and of social science 
knowledge committed to the documentation and elucida-
tion of local cultures, social contexts and community 
mobilization.
Th   is paper seeks to trouble the discourses of biomedical 
pre-eminence in the ﬁ  eld of HIV prevention by examin-
ing the widely touted claim for treatment as prevention, 
looking at evidence constructed through the biomedical 
frame pertaining to this claim and through the lens of the 
sociology of science. It also examines how policy derived 
from population-level analysis and biomedical individua-
lism aﬀ  ects people who must manage HIV risk in their 
everyday lives and social contexts. At the risk of con-
structing too sharp a contrast between two systems of 
knowledge, it should be noted at the outset that even in 
the tsunami example, at least one oﬃ   cial  body,  the 
(United States) National Academy of Sciences [2], called 
for “incorporating the latest social science research on 
hazard education and conducting routine evaluations of 
education programs” as a key element in a larger strategy 
of tsunami preparedness. HIV prevention need not be an 
either/or choice between competing or antagonistic 
knowledge systems; nor is it just a question of 
assimilating a highly technicized version of social science 
as “hazard education and…routine evaluations” into 
biomedicine.
To echo the language of actor-network theory [3,4], it is 
rather a question of how community members, scientists 
and disease entities are networked together into pro-
fessional systems that assemble, order and institutionalize 
problems and their solutions. Th   ese systems marshal the 
lion’s share of resources, formulate policy and shape 
practice intended to impede the advance of the epidemic. 
Th   e choice to fund some professional systems of know-
ledge over others by government, industry and scientiﬁ  c 
funding agencies necessarily has profound consequences 
on how the challenges of epidemics are met. As such, 
these organizational paradigms need critical scrutiny to 
determine what has been included in scientiﬁ  c discourse 
and what has been relegated to the status of “subjugated 
knowledges” [5] to determine how well current con-
catena  tions of knowledge-producing actors address the 
questions: (1) how people and resources are best organ-
ized to stem the continuing proliferation of HIV infec-
tion; and (2) how communities and individual community 
members are best mobilized to avoid HIV without 
sacriﬁ  cing the pursuit of pleasure and intimacy that HIV 
threatens [6].
The inversion of prevention priorities
All of these questions lie within a larger socio-historical 
context of lagging worldwide attention and funding to 
prevention in the HIV area [7]. Th  e subordination of 
prevention is no doubt in part a side eﬀ  ect of the need to 
treat millions who are HIV positive in a world where only 
a minority of those with HIV in the global south have 
access to adequate antiretroviral medication. Associated 
with the perceived imperative to bring treatment to the 
many in need is a trend to assimilate prevention to the 
treatment imperative, grounded on the idea that treat-
ment lowers the population-level viral load and thereby 
lowers the rapidity of HIV transmission [8]. At the same 
time, treatment as prevention has precedents as a strate  gy 
to combat the HIV epidemic as the latest iteration in a 
history of tensions in the prioritization, integration or 
takeover of prevention by treatment [9]. Compounding 
the problem of the small percentage of HIV budgets 
typically falling to prevention, a disproportionate amount 
goes to populations who are not at greatest risk.
A recent report examining the percentage of HIV invest-
ment of the Global Fund To Fight AIDS, Tuberculosis 
and Malaria in high-risk populations ﬁ  nds the following: 
men who have sex with men – US$19 million (2.1% of the 
US$903 million total); sex workers – US$29 million (3.2%); 
and people who inject drugs – US$31 million (3.5%). In 
countries with concentrated epidemics, the report says, 
funding for HIV prevention interventions targeting most-
at-risk populations accounted for 10% of all preventive 
activities, and in countries with generalized epidemics, 
for 4% [10]. Even in generalized epidemics, there is clear 
evidence of much higher rates of HIV infection among 
most-at-risk populations, such as men who have sex with 
men, both in the global south and the global north 
[11-14].
Research investment typically accounts for just a few 
percentage points of HIV prevention budgets and very 
often follows a similar pattern of disproportionate fund-
ing devoted to populations who are not at greatest risk. 
For example, an index search of the Canadian Institutes 
of Health Research Funding Decisions Data website 
(http://webapps.cihr-irsc.gc.ca/cfdd/db_search?p_
language=E&p_competition=EnterCompetitionCodeHere) 
shows a commitment of $98,830,449 to HIV/AIDS 
research overall, of which $22,451,362 contain the word 
“prevention” in funded abstracts, and $9,678,007 also 
contain “IDU”, $2,351,934 contain “sex work”, and 
$2,168,525 contain “men who have sex with men”. In 
other words, 9.7% of the research budget for grants 
mentioning HIV prevention also make any mention of 
men who have sex with men in a country where 51% of 
the epidemic is concentrated among gay and bisexual 
men [15]. Finally, investment in prevention research 
typically goes ﬁ   rst to biomedical technologies [16], 
followed by “intensive practitioner-delivered lifestyle-
change interventions” [17], and least, if any, to investi-
gating community mobilization.
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major international policy documents, often appears 
largely as a question of the development of biomedical 
technologies or interventions, such as vaccines, micro-
bicides, pre-or post-exposure prophylaxis or circum  cision. 
A perusal of plenaries with a central focus on prevention 
in the past ﬁ  ve international AIDS conferences (Barce-
lona 2002, Bangkok 2004, Toronto 2006, Mexico City 
2008, Vienna 2010) shows 13 of the 21 speakers treating 
prevention primarily or exclusively as a biomedical tech-
nology. Th   e remainder show a familiar pattern of repre  sen-
tation of at-risk populations: three speaking on injection 
drug users, two on women (one of whom looked at sex 
work), and one on men who have sex with men (MSM). 
Speakers on HIV prevention in at-risk popu  la  tions were 
typically physicians or public health authori  ties. Social 
science makes a solo appearance with a psycho  logist 
speaking to “conceptual frameworks and HIV/AIDS 
preven  tion paradigms”. A recent review of the 2010 
conference conducted by the Global Forum on MSM and 
HIV notes that taken together across the conference pro-
gramme, “only 2.6%, 4.5%, 3.0% and 1.1% of all sessions 
exclusively focused on MSM, people who use drugs, sex 
workers and transgender people respectively” [18].
Troubling the treatment-as-prevention paradigm
Th   e treatment-as-prevention paradigm is grounded on a 
straightforward proposition: bringing medication to the 
maximum number of people infected with HIV will not 
only bring the promise of greatly enhanced survival and 
quality of life for people living with HIV, but will also 
greatly reduce their viral loads and the likelihood of 
passing the virus onto new people. Universal treatment, 
then, appears to have the potential of having a two-fold 
eﬀ  ect of saving lives while stalling or even reversing the 
progress of the epidemic. It is a proposition that makes a 
good deal of sense from the Olympian viewpoint of 
population-level planning, professionally directed public 
policy, and not coincidentally the proﬁ   tability of the 
multinational pharmaceutical industry.
Closer examination of this paradigm, even from a strictly 
biomedical frame of evidence, shows that it comes with a 
series of qualiﬁ  cations. Th   e evidence for the eﬀ  ectiveness 
of treatment for prevention is pieced together from a small 
set of studies on vertical trans  mission, serodiscordant 
(presumably monogamous) hetero  sexual couples [19], 
ecological studies [20,21], and modelling studies [22].
Equating undetectable viral load with non-infectivity 
falters with problems of equating viral load results in 
blood, semen and vaginal secretions [23-25]. In other 
words, a periodic blood test to determine viral load does 
not guarantee a similar reading in sexually transmitted 
ﬂ   uids. Viral loads turn out, as well, to be somewhat 
unstable [26,27]. “Blips”, that is, periods of elevated viral 
replication, are not unusual especially at times of 
activation of other infections, such as sexually trans-
mitted infections. Given the widespread presence and 
inter  mittent reactivation of long-term viruses like herpes 
virus and human papillomavirus in the general popula-
tion and in at-risk populations in particular, this may not 
be a rare occurrence. Syphilis and hepatitis C outbreaks 
in recent years in major cities of North America and 
Europe [28], particularly among HIV-positive men, point 
to additional limitations to relying on treatment-related 
viral reduction as an assurance for non-transmission.
Accomplishing universal treatment may be no mean 
feat. Taking Canada’s largest province, Ontario, as an 
example, a context of universal medicare and ﬁ  rst-world 
access to treatment (including many dedicated clinics for 
HIV treatment), one ﬁ  nds about a third of the HIV-posi-
tive population reaching undetectable viral load levels 
(Table 1). Estimates for the United States appear to be 
even lower, with 19% of HIV-positive people reaching 
undetectability levels [29]. Accomplishing widespread 
viral undetectability, even in highly-resourced settings, 
then appears to pose major challenges.
Shifting perspective from the population level to that of 
people who must manage risk in their everyday lives 
brings quite another range of considerations into view. 
Recent research done in Australia [30] and the United 
States shows that “men in 2006 endorsed the prevention 
treatment beliefs to a greater degree than men in both 
1997 and 2005…[and] men who engaged in unprotected 
anal sex increased their endorsement of these beliefs” 
[31]. And though belief about treatment eﬀ  ectiveness 
may inﬂ   uence (un)safe sex practice, unprotected anal 
inter  course among HIV-positive men does not appear to 
be associated with actual viral load [32,33]. Furthermore, 
unprotected anal intercourse appears to be associated 
with non-adherence to medication [34], a practice very 
likely to compromise the maintenance of undetectable 
viral load. Undetectability, in any case, is not the same as 
the absence of circulating virus; it refers only to the limit 
of testing capability, which is typically 50 copies per 
milliliter.
DP Wilson [35] and colleagues estimate that over the 
course of a relationship of repeated exposure to “undetec-
table” virus, in a population of 10,000 serodiscordant 
couples over 10 years, there would still be 215 trans-
missions from HIV-positive women to HIV-negative 
Table 1. Treatment status of HIV-positive people in Ontario
~9300 HIV+ people do not know they have HIV infection  35%
1700 diagnosed but not in care, i.e. have not had a viral load test  6%
3440 in care but not on ARV  13%
3630 in care, on ARV, and have detectable viral load  14%
8470 have undetectable viral load  32%
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negative women; and 3524 transmissions from HIV-
positive men to HIV-negative men. Timothy Hallett [36] 
and colleagues estimate that “men receiving treatment 
pose a substantial risk of HIV transmission (22%; 9-37% 
in uncertainty analysis) to their partners if they do not 
use condoms”. Th   e male-to-male transmission rate raises 
questions of just which popu  la  tion is intended by 
population-level analysis, particularly in epidemics in the 
global north where men who have sex with men typically 
account for half of current HIV transmissions.
Epistemic fault lines: population health and 
everyday risk
Th  e treatment-as-prevention paradigm, then, deserves 
some caution even when read from inside a biomedical 
frame of reference, but perhaps even more problematic is 
the relationship of the entire paradigm to the larger world 
of collective risk management. Treatment as prevention 
and population health science almost always proceed 
from a series of premises grounded in positivism where 
practices, characteristics and attributes are abstracted 
from context and ﬁ  xed into place as variables, and then 
correlated through probabilistic statistics. Th  ese mathe-
matical manipulations produce a form of actuarial reason-
ing compatible with the standpoint of state agencies and 
capitalist enterprises.
Th  e  diﬃ   culty with this is the fundamental disjuncture 
between this form of reasoning and the reasoning 
inherent in navigating risk in everyday life. For example, 
the insurance industry constructs the category of the 
high-risk driver as male and under the age of 25 (and 
penalizes everyone falling into this category with sharply 
elevated insurance premiums), yet this ﬁ  nding oﬀ  ers little 
of value to young men, or even to other drivers who 
encounter young male drivers on the road, on how to 
drive safely or even reduce driving risk in any way.
In HIV research, actuarial paradigms produce informa-
tion that is notoriously diﬃ   cult to translate into preven-
tion practice or advice for those who must cope with HIV 
risk every day. While probabilistic statistics may be able 
to identify “signiﬁ  cant” diﬀ  erences in risk, based on a 
spread of a few percentage points on a variable, HIV 
infection is a binary: you either get it or you do not. 
Cindy Patton [37] typiﬁ  es this fault line as one between 
“witnessing disease” at the population level and “witness-
ing illness”, arguing, “Because witnessing disease claims 
its superiority on the basis of population-level viral 
reduction and cost, treatment-as-prevention programs 
cannot ‘see’ the individual” as an actor who must manage 
disease, or risk of disease, in everyday life.
Bringing population-level reasoning to grassroots 
practice can, at times, produce paradoxical or noxious 
results. Some recent research [38], for example, shows 
that younger men who have older partners have higher 
rates of seroconversion compared with those who do not 
(a ﬁ   nding precedented by research on age-mixing in 
African heterosexual transmission and among injection 
drug users). Th  e ﬁ   nding shows impeccable abstracted 
positivist logic: A correlates with B, and therefore 
something should be done. But what? An editorial in the 
Journal of Acquired Immune Deﬁ  ciency Syndromes [39] 
raises the alarm that public health oﬃ   cials have not yet 
acknowledged that age mixing can be a signiﬁ  cant driver 
in HIV epidemics”.
Of course, this logic can easily be extended outward. 
Latino men, and even more so, African American men, 
have higher rates of HIV. Men who have receptive sex 
have higher rates of HIV. And all of these measures are 
just proxies for HIV positivity, so obviously people living 
with HIV have a 100% HIV rate. So the average gay man 
is to select only young, white, HIV-negative partners who 
are exclusive tops and all will be well? Th  is kind of 
reasoning remains resolutely asocial, ahistorical and out 
of tune with basic human psychology. It has no context, 
no sense of social interaction, and cares nothing for real 
risk management. It takes no interest in the ways in 
which public health advice of this type stokes racism, 
ageism, homophobia and AIDS phobia, and how the 
heightening of invidious social distinctions of this kind 
ultimately contributes to precisely the social dynamics of 
stigma that shut down disclosure, disempower those on 
the receiving end of discrimination, and heighten risk 
[40,41]. Fortunately male desire will never be disciplined 
by this kind of authoritarian positivism and men will 
continue to love, care for, and have sex with men across 
age, sex, race and sero-status lines.
Th   e result is a population science establishment divided 
over an epistemic fault line from the communities and 
individuals who must make sense of the intrusion of a 
life-threatening disease into their pursuit of pleasure and 
intimacy. While the “social determinants of health” para-
digm in health research does at least recognize a world 
beyond biology that is inﬂ  uential in human health, it still 
remains ﬁ  rmly ensconced on the “population health” side 
of the epistemic fault line. It is on this fault line that are 
built various “knowledge translation and exchange” (KTE) 
enterprises and “community-based research” (CBR) 
initiatives where community members are brought in to 
monitor the apparently nefarious ways of researchers.
At its best, CBR and KTE do engage community 
members at every stage of the research process, though 
this engagement may or may not be facilitated by the 
fundamental logic of the research paradigm. At its worst, 
KTE becomes a pipeline designed to push through 
popular resistance in order to reassert the population 
health paradigm and CBR devolves to AIDS service 
organizations to act as a communication circuit or buﬀ  er 
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epidemic, though they are often not in a position to have 
the skills or resources to carry out a mandate of this sort. 
Th  e question that remains is: why can there not be 
prevention knowledge that starts from the grounded 
experience of people who deal most directly with HIV risk 
rather than starting from a population level of analysis?
Epistemic fault lines: prevention technologies and 
practices
Th  ere can be no doubt that additional eﬀ  ective preven-
tion technology would be most welcome in the realm of 
HIV prevention. Th  irty years since the identiﬁ  cation of 
HIV, the rather low-tech condom remains the primary 
defence against sexual transmission of HIV, and it is a 
technology with well-known drawbacks in physical sen-
sa  tion and the expression of intimacy. During that time 
period, a good deal of research money has been poured 
into prevention technologies in the treatment-as-preven-
tion strategy and beyond. Th   e problem is, of course, that 
vaccines, microbicides, pre- and post-expo  sure prophy-
laxis, and circumcision have had only very limited 
success [42]. An eﬀ  ective vaccine still appears to be a 
long way oﬀ  . Circumcision may have some impact on the 
epidemiological numbers, particu  larly in general  ized, 
largely heterosexual epidemics in populations where 
circumcision is currently low, though even this claim is 
not without its critics [43]. It seems likely to have only 
negligible eﬀ   ect in countries with other epidemic 
patterns. Recent research in pre-exposure prophylaxis is 
showing approximately 39% to 44% eﬀ  ectiveness [44,45] 
and may ﬁ  nd a place as a supplement to condom use, but 
scarcely as a replacement for it.
Perhaps the most striking, but inadvertent, lesson to be 
drawn from these studies is that all biomedical preven-
tion technologies are also social interventions, whether 
that is explicitly recognized or not. Pre-exposure prophy-
laxis, like condom use, is clearly strongly dependent on 
“adherence”, a term often associated with patient recalci-
trance and management, but which glosses the very large 
realm of how interventions ﬁ  t with everyday exigencies, 
cross-cutting demands of home and workplace, available 
options, economic resources and interpretive frameworks 
of the people who are to adopt these technologies.
Th  ere are nevertheless some well-recognized HIV 
preven  tion success stories, for example: the Songachi 
project in India and the 100% Condom Programme in 
Th   ailand among sex workers; mobilization among injec-
tion drug users and development of needle exchange and 
safe injection sites; and the mobilization of gay and 
bisexual men in Europe, North America and Australia in 
the 1980s and 1990s. All of these examples resulted in 
major reductions of HIV infection in diverse populations. 
If there is a common thread running through these 
examples, it is that the success of relatively low-tech 
prevention strategies, based on condom use or needle 
exchange, comes about only through the cooperation and 
coordination of all relevant stakeholders, from local 
government, public health and related business sectors 
through to community organizations and most impor-
tantly, to aﬀ  ected populations themselves.
Th   e United Nations report on the Th   ai 100% Condom 
Programme concludes that eﬀ  ectiveness was dependent 
on a “collaborative eﬀ  ort among local authorities, public 
health oﬃ   cers, sex establishment owners, and sex workers 
to ensure that clients could not purchase sexual services 
without condom use in the province”. When the pro-
gramme was implemented, rates of sexually transmitted 
infections dropped “quickly and signiﬁ  cantly” [46]. (Lack 
of comparable concentrated eﬀ   ort in addressing the 
epidemic among men who have sex with men in Th  ailand 
has resulted in rising rates [47].)
Reviews of the Songachi project come to a similar 
conclusion. At the community level, this included: (1) re-
deﬁ  ning the problem in a way that does not stigmatize 
individuals; (2) helping the community assume responsi-
bility by highlighting ways in which the short- and long-
term beneﬁ  ts of implementing safer acts are apparent 
both for the individual and the community; (3) reducing 
environmental barriers to implementation; and (4) pro-
vid  ing resources. Th  e group level of change involved 
building relationships among those in the target popu-
lation, between sex workers and stakeholders, and 
between the initial change agents and sex workers, thus 
building a supportive network to sustain the programme 
over time. At the individual level, the programme pro-
vided information and education, built skills and 
addressed social perceptions of the sex workers [48].
Drug users succeeded in reducing drug-related harm 
through small group activities and, in some instances, 
formal organizations in several locales in the early days of 
the epidemic [49]. Needle exchange programmes clearly 
require the cooperation of legal regimes and municipal 
authorities, including police, public health, outreach 
workers, and drug-using networks and individuals [50].
Gay communities in the global north were among the 
ﬁ  rst to respond to the AIDS crisis, building on networks 
developed in recent years of community and movement 
formation and impelling health establishments and state 
agencies to overcome inertia, even antipathy [51-55]. Th  e 
result was a rapid, major reform of sexual behaviour and 
a sharp drop in HIV infection over the course of a decade.
Perhaps especially notable about these prevention 
successes is that they typically employ remarkably low-
tech solutions among populations that receive slim 
allocations of restricted prevention budgets. Th  ey also 
pose signiﬁ  cant questions to social science concerning 
the ways in which at-risk populations develop strategies 
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these strategies are best supported by community, state 
and sometimes business organizations around them. 
Prevention good-news stories of this kind are clearly just 
the beginning of an adequate strategy for stemming HIV 
transmission, but scarcely enough in themselves. Men 
who have sex with men, for example, despite impressive 
gains in the ﬁ  rst two decades of the epidemic, continue to 
be infected at rates more than 44 times that of the men 
around them [56].
Techno-eschatology, or why there needs be a 
robust social science agenda
Professional knowledge systems in HIV, then, have 
invested heavily in biomedical technologies and have 
privileged particular paradigms in the health sciences, 
leaving other knowledge networks relatively under-
developed and under-resourced. Much of the ﬁ  rst 
decades of HIV have been characterized by a certain 
“techno-eschatology”, that is, a tendency to wait for a 
deﬁ   nitive answer or historical turning point to be 
delivered by science and technology. Th  at tendency to 
keep waiting for deliverance from an epidemic that has 
already killed 25 million has tended to divert attention 
away from what has and can be accomplished now.
Impeding the epidemic is work that needs tools 
available in the social sciences. Th   ese include examining 
how HIV moves (or is slowed) according to: the ways that 
people are socially organized and networked; the popular 
strategies and folk wisdoms developed in the face of HIV 
risk; socio-historical movement of sexual and drug 
cultures; the dynamics of popular mobilization to advance 
health; the institutional sources of HIV discourses; and 
popular understandings of HIV technologies and messages.
The ways that people are socially organized and networked
Epidemiological categories (e.g., men who have sex with 
men, people from endemic countries, low-risk hetero-
sexuals) have heuristic value as counting devices, but are 
inadequate proxies for the ways in which people do, in 
fact, interact with each other, and translate badly over the 
epistemic divide into everyday experience. How people 
are socially organized and networked is important for 
understanding the patterns of movement of HIV and also 
for the ways in which people can be reached or mobilized 
for prevention [57-60].
Molecular epidemiology has much to contribute to 
delineating the uneven bursts of HIV transmission that 
make up the larger epidemic [61,62], but there is much to 
be learned about how people on the leading edge of the 
epidemic are networked with each other, and the aware-
ness they may have of their own sero-status and of those 
in their immediate social environments. Psycholo  gical 
research has identiﬁ   ed a range of variables asso  ciated 
with unprotected anal intercourse and Ron Stall [63] and 
associates have adopted the term, “syndemic”, to refer to 
this coincidence of epidemics of childhood sexual abuse, 
depression, partner violence and polydrug use. Th  is  and 
perhaps other syndemics have a social face as well – 
circuits, micro-cultures, social niches and social 
networks – and yet there is insuﬃ   cient ethnography of 
these most vulnerable subsets of at-risk populations.
The popular strategies and folk wisdoms that developed in 
the face of HIV risk
Counting risk “behaviour”, widespread in the health 
sciences, tells us only so much [64]. Less is known about 
practices embedded in the exigencies and choices of 
everyday life, or the popular strategies and folk wisdoms 
for staying healthy [65,66]. Bio-technologies are also 
dependent on everyday practices; their use or disuse 
cannot simply be put down to “inadequate uptake” or a 
failure to be rational. Th  e research question here is to 
investigate discourses available for making sense of risk. 
Th   is means delving into, and working on, popular know-
ledge, moral reasoning and cultural presumptions that 
reduce (or enhance risk), and documenting narratives 
rooted in cultures of at-risk communities. Th  is is not 
simply to aﬃ   rm these practices and perceptions but to 
engage with them, work with them and develop know-
ledge grounded in them. Th   ere is evidence, for example, 
that some of the vulnerabilities to transmission occurring 
among gay and bisexual men stem not from inadequate 
knowledge or psychological deﬁ  ciencies, but rather from 
inconsistent assumptions and interpretations of the 
“rules of the game” governing sexual interactions [58].
Socio-historical movement of sexual and drug cultures
Th  ese are the master frameworks through which risk, 
values and, indeed, risks worth taking are assessed. Th  e 
entire expensive, painstakingly evaluated ediﬁ  ce  of 
intensive practitioner-delivered lifestyle-change interven-
tions, with the Eﬀ  ective Behavioral Intervention im  primatur 
of the Centers for Disease Control and Prevention, rise or 
fall on this movement. Th  e intervention that may be 
fascinating and fashionable at one moment can turn out 
to be stale and passé at another. Th   ese movements shape, 
as well, the experience of entire generations and intersect 
with the personal development of individuals in the 
moving cultures in which they participate [67]. To pick 
just one example, social research is only beginning to 
come to grips with the rapid virtualization of the sexuality 
of a wired generation that has ready access to imagery 
and internet networks well before embarking on practice.
The dynamics of popular mobilization to advance health
Social movement analysis has rarely been applied to 
successful HIV health mobilization, but Toorjo Ghose 
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Th  ough this framework is not often thought of in 
reference to drug users, they too can be understood as 
collective actors.
While injection drug users (IDUs) have clearly changed 
their behaviour to protect themselves from becoming 
infected with HIV, they have also dramatically changed 
their behaviour to protect their peers and sexual partners 
from becoming infected. IDUs have shown multiple 
altruistic responses to HIV/AIDS. Th  e development of 
new social norms against sharing needles and syringes is 
one example. Th  e eﬀ  ectiveness of HIV prevention for 
IDUs should not be viewed only in terms of programmes 
inﬂ   uencing individuals, but also more as a collective 
response by the IDU community to reduce HIV risk 
behaviour [60].
While lesbian, gay, bisexual and transgendered (LGBT) 
communities have been perhaps the textbook case of 
community mobilization, recent observers question if 
this is a historical moment that has passed as these com-
munities appear to be fragmenting into smaller scenes 
and groups [69]. Th  e political organization of LGBT 
communities has moved in a similar direction toward 
focused, diversiﬁ   ed and multiple organizational nodes 
that are nevertheless still connected rhizomatically, that 
is, through often informal, ad hoc, and not readily visible 
networks [70]. Th  is more decentralized, tribalized form 
of social connection is fundamental to understand as 
prevention work must adapt to the multiplicity of 
networks and their cultures.
Th   ere are several challenges that present themselves in 
understanding and engaging contemporary forms of 
com mu nity  mobilization.  Th  e ﬁ   rst is to delineate the 
smaller scenes, micro cultures, tribes and subsets of at-
risk populations so that their discourses and concerns 
might be better addressed. In addition, there may still be 
potential in generating social forums for “communicative 
action”, a signiﬁ  cant vehicle for social change according 
to the leading social theorist, Jürgen Habermas [71], and 
one of the few available to HIV prevention. Both 
strategies could make good use of social media especially 
to engage a wired generation that is connected and 
accessible in new ways.
One major intervention of this kind is hivstigma.com, 
an innovative web-supported stigma-reduction interven-
tion for gay and bisexual men, a project intended to open 
a forum to allow community members to advance a 
dialogue on community ethics with direct impact on 
practices related to HIV transmission [41]. Relying on 
traditional and new media of communication, hivstigma.
com provided virtual space to develop community 
engagement with the question of HIV stigma. Th  is  inter-
vention also raises the question of whether decentralizing 
trends among gay and bisexual men should be treated 
simply as a given. Th  e creation of a communication 
centre, this time in cyberspace, revealed an appetite for 
community-wide dialogue and a willingness to engage a 
sense of collective fate that could be aﬀ   ected by the 
everyday practices of HIV-positive and HIV-negative men.
The institutional sources of HIV discourses
Understanding risk perception necessitates research on 
institutional sources inﬂ  uencing both popular and policy 
orientations to the epidemic. Schools, mass media, 
churches and mosques, the judiciary, biomedicine and 
the Internet are all major actors in framing the meaning 
of HIV and the means for addressing HIV risk. Indeed 
they are actors with much more institutional solidity and 
pervasive inﬂ   uence than all of the community-based 
organizations and public health authorities devoted to 
HIV prevention. Just what kinds of messages ﬂ  ow from 
these institutions and the “semiotic snares” [72,73] they 
create in everyday practice are fundamental to making 
sense of how and why transmission occurs.
Popular understandings of HIV technologies and messages
Just how the actuarial reasoning of health science 
translates into personal risk strategies requires investi-
gation. HIV technologies and messages occur in a context 
of communication in relationships, workplace exigencies, 
and popular moral reasoning. Even the widespread claim 
that gay men have become complacent because of 
antiretrovirals is poorly documented. Th   e HIV optimism 
hypothesis functions more as an observer’s rule [74], that 
is, an explanation that “makes sense” and circulates 
among scientists, than it does as a rule of thumb for gay 
and bisexual men themselves. Actual investigation of the 
views of gay and bisexual men assessing risk in their day-
to-day interactions typically ﬁ  nds a much more complex 
array of considerations. HIV optimism carries very 
diﬀ   erent meanings for HIV-positive and HIV-negative 
men and plays, at most, a minor role in risk situations 
[40,75]. Also, how the treatment-as-prevention mantra 
propounded by biomedical “experts” translates into 
everyday risk management is not well documented.
Conclusions
Th   is paper raises the question of how knowledge creation 
is organized in the area of HIV prevention and how this 
concatenation of expertise, resources, at-risk people and 
viruses shapes the knowledge used to impede the 
epidemic. Much of the organizational and investment 
centre point of HIV prevention appears to be occupied 
by a search for biomedical technologies, and perhaps 
more importantly by an epistemological frame charac-
teristic of biomedical individualism [72,76]. Th  is frame 
largely bypasses the social, or assigns it to categories of 
“inadequate uptake”, patient management or the residual 
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into the frame, it is very often in the form of “experi-
mental manipulations [that] remove the very stuﬀ   that 
produces change – the social glue that makes us social 
beings” [17].
At its best, HIV prevention studies could look toward 
  ways in which biomedical and social approaches to HIV 
prevention would work synergistically [77] by moving 
past the techno-eschatology that currently characterizes 
much of the ﬁ  eld and working seriously with the social 
and community resources already at hand.
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